• Myeloma UK
  • Clinical Service Excellence Programme
Myeloma Academy
Sign inRegister
Menu
  • Home
  • CPD & Learning
    • Myeloma Nurse Learning Programme
    • My CPD Portfolio
    • Challenging Cases
    • Close
  • Library
    • Guidelines
      • Complications
      • COVID-19 guidance
      • General haemato/oncology
      • Imaging & Analysis
      • Management & Treatment
      • Palliative Care
      • Presentation & Diagnosis
      • Related conditions
      • Close
    • Patient Support and Information
    • Medical animations
    • Remote consultation video
    • Close
  • Resources
    • Myeloma Drug Finder
    • Myeloma Trial Finder
    • Assessment tools
    • Myeloma Spotlight
    • Primary care education
    • Secondary care education
    • Myeloma Nurse Guides
    • Myeloma health economic model
    • Laboratory Practice
    • Close
  • News & Events
    • News
    • Event calendar
    • Meeting highlights
    • Close
  • CSEP
  • About Us
    • Contact Us
    • Close
Menu back  
 

Related conditions

Investigation and management of monoclonal gammopathy of undetermined significance

July 3, 2023Clinical guidelines & position statements, Library, Related conditionsBy hparkin

This Good Practice Paper provides recommendations for the diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance (MGUS).

Read the paper here.

Diagnosis and Investigation of AL Amyloidosis

October 30, 2014BCSH/UKMF, Clinical guidelines & position statements, Library, Related conditionsBy hparkin

This guideline outlines recommendations for the diagnosis and investigation of patients with suspected AL amyloidosis.

Read more

Management of AL amyloidosis

October 9, 2014BCSH/UKMF, Clinical guidelines & position statements, Library, Related conditionsBy hparkin

These guidelines outline recommendations for the management of patients with AL amyloidosis, including treatment, monitoring and how to measure response.

Read more

Guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance

August 13, 2014BCSH/UKMF, Clinical guidelines & position statements, Library, Related conditionsBy MaggieLai

These guidelines, written by the UK Myeloma Forum in conjunction with the Nordic Myeloma Study Group provide guidance for the effective clinical investigation of patients with newly detected paraprotein and the practical management of patients with monoclonal gammopathy of undetermined significance (MGUS).

Download

IMWG Consensus perspectives: risk factors for progression and guidelines for monitoring and management of MGUS and smouldering myeloma

August 11, 2014Clinical guidelines & position statements, IMWG, Library, Related conditionsBy MaggieLai

In this article, members of the International Myeloma Working Group review the available data and provide new recommendations for the management of MGUS and smouldering myeloma patients.

Read abstract

Plasma cell leukaemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the IMWG

August 11, 2014Clinical guidelines & position statements, IMWG, Library, Related conditionsBy MaggieLai

This article, written by the International Myeloma Working Group, reviews the evidence and provides a consensus on the diagnostic criteria, response criteria and treatment recommendations for primary plasma cell leukemia.

Download
  • Guidelines
    • Complications
    • COVID-19 guidance
    • General haemato/oncology
    • Imaging & Analysis
    • Management & Treatment
    • Palliative Care
    • Presentation & Diagnosis
    • Related conditions
  • Patient Support and Information
  • Medical animations
  • Remote consultation video
Bottom menu

Charity No. SC 026116
Myeloma UK
22 Logie Mill
Beaverbank Business Park
Edinburgh
EH7 4HG